Cancer immunotherapy and vaccine development have significantly improved the fight
against cancers. Despite these advancements, challenges remain, particularly in the clinical …

The combination of peptides and nanoparticles in cancer therapy has shown synergistic
results. Nanoparticle functionalization with peptides can increase their targeting ability …

As an emerging cancer treatment strategy, ferroptosis is distinguished by the perturbation of
lipid metabolism equilibrium and the accumulation of lipid peroxidation. However, the …

Background The combination of programmed cell death ligand-1 (PD-L1) immune
checkpoint blockade (ICB) and immunogenic cell death (ICD)-inducing chemotherapy has …

The combination of immune checkpoint blockade (ICB) and chemotherapy has shown
significant potential in the clinical treatment of various cancers. However, circulating …

The convergence of nanotechnology and cancer therapeutics has opened new frontiers in
the development of advanced drug delivery systems. Among the various nanocarriers …

Despite all major advancements in drug discovery and development in the pharmaceutical
industry, cancer is still one of the most arduous challenges for the scientific community. The …

Cancer is the leading cause of death globally, and conventional treatments have limited
efficacy with severe side effects. The use of nanotechnology has the potential to reduce the …

Three-dimensional bioprinting leverages computer-aided design to construct tissues and
organs with specialized bioinks. A notable biomaterial for this purpose is chitosan, a natural …

Lipid nanoparticles (LNPs) exhibit remarkable mRNA delivery efficiency, yet their majority
accumulate in the liver or spleen after injection. Tissue‐specific mRNA delivery can be …